今海医疗科技股份有限公司（股份代号：02225）于2026年6月1日发布截至2026年5月31日的月报表。公告显示，公司法定/注册股本维持与上月相同，数额为2,000万港元，股份面值为每股0.0025港元，法定/注册股份总数保持在80亿股。
在已发行股份方面，5月期内公司普通股数量由上月底的52.90亿股增加至52.99亿股，增发9,000,000股。库藏股数量持续为0，已发行股份套数相应增长至52.99亿股。
根据公告，本月新增股份主要来自2023年12月29日采纳的股份期权计划，共计有9,000,000股期权被行使，公司由此获得认股款项5,715,000港元(折合约571.50万港元)。期末公司拥有445,960,000份未行使的股份期权，若全部行使，预计可发行相应数目的新股。
公司确认已符合适用的香港联交所最低公众持股量要求，并表示本月所有相关股份发行均遵守相关上市规则及法规。该公告由公司秘书黄文耀签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.